Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -14.68%239.05M | -13.34%545.09M | -10.22%280.18M | -7.11%629M | -9.39%312.09M | -7.97%677.17M | -6.99%344.43M | 5.17%735.78M | 9.97%370.32M | -14.99%699.62M |
| Operating income | -14.68%239.05M | -13.34%545.09M | -10.22%280.18M | -7.11%629M | -9.39%312.09M | -7.97%677.17M | -6.99%344.43M | 5.17%735.78M | 9.97%370.32M | -14.99%699.62M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Profit from asset sales | 369.23%35K | 480.00%986K | -208.33%-13K | -98.50%170K | -99.89%12K | 2,846.60%11.32M | 1,878.32%11.32M | -177.44%-412K | 489.69%572K | 8.57%532K |
| Employee expense | 6.44%-167.13M | 6.19%-346.2M | 3.77%-178.64M | 3.15%-369.05M | 2.92%-185.64M | 1.70%-381.03M | 3.97%-191.22M | 13.08%-387.61M | 12.39%-199.11M | 13.48%-445.94M |
| Depreciation and amortization | -1.98%-10.66M | 32.98%-21.88M | 35.53%-10.45M | -2.73%-32.64M | -4.14%-16.21M | 3.86%-31.78M | 7.50%-15.57M | 2.94%-33.05M | 0.07%-16.83M | 33.49%-34.05M |
| Revaluation surplus | 23.71%-7.9M | -520.58%-13.15M | -58.02%-10.36M | -105.44%-2.12M | ---6.55M | 75.28%38.95M | ---- | -43.40%22.22M | ---- | 171.50%39.26M |
| -Changes in the fair value of investment property | 23.71%-7.9M | -171.30%-12.26M | -58.02%-10.36M | -111.70%-4.52M | ---6.55M | 73.78%38.61M | ---- | -44.31%22.22M | ---- | 174.98%39.9M |
| -Changes in the fair value of financial assets | ---- | -137.08%-890K | ---- | 605.88%2.4M | ---- | 11,233.33%340K | ---- | 100.47%3K | ---- | 62.61%-636K |
| Impairment and provision | ---- | ---- | ---- | -150.86%-5.22M | ---5.22M | --10.27M | ---- | ---- | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---5.22M | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---- | -150.86%-5.22M | ---- | --10.27M | ---- | ---- | ---- | ---- |
| Special items of operating profit | -3.23%-51.8M | 20.07%-100.16M | 20.20%-50.18M | -12.02%-125.31M | -37.40%-62.88M | 18.51%-111.86M | 29.45%-45.76M | -111.73%-137.27M | -1,632.10%-64.87M | 64.74%-64.83M |
| Operating profit | -94.74%1.61M | -31.78%64.69M | -14.17%30.55M | -55.49%94.83M | -65.52%35.59M | 6.70%213.04M | 14.55%103.2M | 2.61%199.66M | 1.23%90.09M | 976.83%194.58M |
| Financing cost | 15.13%-258K | 58.52%-582K | 63.29%-304K | -443.80%-1.4M | -500.00%-828K | 6.52%-258K | 1.43%-138K | -2.60%-276K | -9.38%-140K | -5.49%-269K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --133K | 238.27%41.63M |
| Earning before tax | -95.54%1.35M | -31.38%64.11M | -13.00%30.24M | -56.09%93.42M | -66.27%34.76M | 6.72%212.78M | 14.41%103.06M | -15.50%199.39M | 1.37%90.08M | 2,018.90%235.95M |
| Tax | 103.57%174K | 34.86%-11M | -64.30%-4.88M | 59.66%-16.88M | 83.04%-2.97M | -32.82%-41.86M | 9.42%-17.51M | -36.32%-31.51M | -1,180.13%-19.33M | -3,271.06%-23.12M |
| After-tax profit from continuing operations | -94.00%1.52M | -30.61%53.11M | -20.21%25.36M | -55.22%76.54M | -62.84%31.79M | 1.82%170.92M | 20.92%85.55M | -21.12%167.87M | -19.01%70.75M | 1,939.98%212.83M |
| Earning after tax | -94.00%1.52M | -30.61%53.11M | -20.21%25.36M | -55.22%76.54M | -62.84%31.79M | 1.82%170.92M | 20.92%85.55M | -21.12%167.87M | -19.01%70.75M | 1,939.98%212.83M |
| Minority profit | -9.81%239K | -53.33%673K | -74.64%265K | -66.92%1.44M | 21.65%1.05M | 285.75%4.36M | 267.09%859K | -29.06%1.13M | 735.71%234K | 374.66%1.59M |
| Profit attributable to shareholders | -94.89%1.28M | -30.18%52.43M | -18.36%25.1M | -54.91%75.1M | -63.70%30.74M | -0.11%166.56M | 20.10%84.69M | -21.06%166.74M | -19.25%70.52M | 2,022.62%211.24M |
| Basic earnings per share | -95.24%0.0005 | -30.03%0.0219 | -17.97%0.0105 | -54.96%0.0313 | -63.74%0.0128 | 0.00%0.0695 | 20.07%0.0353 | -21.11%0.0695 | -19.23%0.0294 | 1,815.22%0.0881 |
| Diluted earnings per share | -95.24%0.0005 | -30.03%0.0219 | -17.97%0.0105 | -54.96%0.0313 | -63.74%0.0128 | 0.00%0.0695 | 20.07%0.0353 | -21.11%0.0695 | -19.23%0.0294 | 1,815.22%0.0881 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Hang Kin Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.